CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to identify biomarkers that predict patient responses to immunotherapy in advanced non-small-cell lung cancer and melanoma. By integrating various omics analyses and liquid biopsy techniques, it seeks to enhance the understanding of treatment outcomes and enable non-invasive monitoring of cancer thera…
The development of immunotherapies based on checkpoint inhibitors marks the beginning of a new era in the treatment of cancer, with 20-30% of tumor response in advanced non–small-cell lung cancer and melanoma.
However, the rational use of these agents has been limited by the lack of definitive predictive biomarkers.The recent “omics revolution” provides great opportunities to elucidate the biological processes linked to the treatment outcome.
Here we propose a multilayer integrative omics analys…
FUNDACION PARA LA INVESTIGACION DE MALAGA EN BIOMEDICINA Y SALUD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
